What have pharmacies paid for Meloxicam since 2013?
What pharmacies pay, not what you pay. Meloxicam has 5 products in the CMS NADAC survey, 5 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Meloxicam 15 MG Tablet: $0.026 per unit at the 2013 survey and $0.018 at 2026 (−30%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Meloxicam5 products in NADAC
5products with a price history
Meloxicam has 5 products in the CMS NADAC survey, 5 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
Between each product's first and latest year-end survey, 2 products cost pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
3 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.
Meloxicam 15 MG Tablet
Generic
$0.026 per unit at the 2013 year-end survey (23 NDCs) and $0.018 at the 2026 survey (23 NDCs): −30%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2013 (2013-12-25)
$0.026
23
2014 (2014-12-31)
$0.028
23
2015 (2015-12-30)
$0.024
27
2016 (2016-12-28)
$0.022
26
2017 (2017-12-27)
$0.020
23
2018 (2018-12-26)
$0.019
21
2019 (2019-12-25)
$0.022
17
2020 (2020-12-30)
$0.020
17
2021 (2021-12-29)
$0.023
18
2022 (2022-12-28)
$0.024
18
2023 (2023-12-27)
$0.022
19
2024 (2024-12-25)
$0.018
21
2025 (2025-12-31)
$0.020
20
2026 (2026-11-11)
$0.018
23
Meloxicam 7.5 MG Tablet
Generic
$0.026 per unit at the 2013 year-end survey (20 NDCs) and $0.017 at the 2026 survey (23 NDCs): −36%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2013 (2013-12-25)
$0.026
20
2014 (2014-12-31)
$0.022
20
2015 (2015-12-30)
$0.023
26
2016 (2016-12-28)
$0.021
23
2017 (2017-12-27)
$0.018
23
2018 (2018-12-26)
$0.018
21
2019 (2019-12-25)
$0.019
18
2020 (2020-12-30)
$0.019
18
2021 (2021-12-29)
$0.022
19
2022 (2022-12-28)
$0.021
18
2023 (2023-12-27)
$0.021
19
2024 (2024-12-25)
$0.016
21
2025 (2025-12-31)
$0.017
20
2026 (2026-11-11)
$0.017
23
Meloxicam 7.5 MG/5 ML Susp
Generic
$0.736 per mL at the 2013 year-end survey (1 NDC) and $0.869 at the 2016 survey (1 NDC): +18%, a thin comparison.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per mL
Lowest to highest
NDCs priced
2013 (2013-12-25)
$0.736
1
2014 (2014-12-31)
$0.677
1
2015 (2015-12-30)
$0.882
1
2016 (2016-12-28)
$0.869
1
Meloxicam 10 MG Capsule
Generic
$10.63 per unit at the 2024 year-end survey (2 NDCs) and $10.76 at the 2026 survey (2 NDCs): +1%, a thin comparison.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2024 (2024-12-25)
$10.63
2
2025 (2025-12-31)
$9.71
2
2026 (2026-11-11)
$10.76
2
Meloxicam 5 MG Capsule
Generic
$8.74 per unit at the 2024 year-end survey (2 NDCs) and $8.28 at the 2026 survey (2 NDCs): −5%, a thin comparison.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2024 (2024-12-25)
$8.74
2
2025 (2025-12-31)
$8.26
2
2026 (2026-11-11)
$8.28
2
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
Where does Meloxicam sit on the generic price cliff?
Meloxicam 10 MG Capsule: the first generic approval in its Orange Book group is dated 2020. Its year-end acquisition cost in 2026 is 101% of its first observed year-end price (2024). The median matched product, 6 years after its first generic approval, is at 45% (the middle half runs from 16% to 87%), so this product is above that middle half.
median of 200 matched productsmiddle halfeach productMeloxicam 10 MG Capsule
This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.